文献速递牙周病

IL-1β阳性中性粒细胞在牙周炎小鼠骨调节中的作用

[Preliminary study on the role of IL-1β+ neutrophils in bone regulation of periodontitis mice].
PubMed 文献 · Zhonghua Kou Qiang Yi Xue Za Zhi · 2026-01-01

该研究通过牙龈卟啉单胞菌诱导小鼠牙周炎模型,发现病变上颌骨中IL-1β+中性粒细胞比例显著增加,并抑制成骨细胞前体MC3T3-E1的成骨分化,该过程与TLR4-NF-κB信号通路相关,为牙周炎骨再生的免疫治疗提供依据。

要点

  • 牙周炎小鼠病变颌骨中IL-1β+中性粒细胞比例显著升高。
  • IL-1β+中性粒细胞可抑制MC3T3-E1细胞的成骨分化。
  • TLR4抑制剂可部分或全部逆转上述变化。

核心结论

  • IL-1β+中性粒细胞在牙周炎小鼠病变颌骨中显著增加,抑制MC3T3-E1细胞成骨分化,并与TLR4-NF-κB信号通路相关。

研究设计与样本

  • 采用口腔局部感染Pg建立小鼠牙周炎模型,将20只8周龄雄性C57BL/6J小鼠随机分为对照组和PD组,每组10只。
  • 结合显微CT、单细胞转录组测序、HE染色、免疫组织化学染色、流式细胞术和免疫荧光染色分析体内变化。
  • 体外用Pg刺激中性粒细胞,分选IL-1β+中性粒细胞与MC3T3-E1共培养,评估成骨分化及TLR4-NF-κB通路变化。

主要发现

  • PD组小鼠颊侧CEJ-ABC为(232.90±25.29)μm,显著高于对照组(149.50±16.69)μm(P<0.001);腭侧CEJ-ABC为(190.70±10.67)μm,亦显著高于对照组(151.80±11.29)μm(P<0.001)。
  • 单细胞转录组测序显示PD组中性粒细胞分布比例为(0.62±0.04),显著高于对照组(0.44±0.05)(P=0.010),且IL-1β在中性粒细胞中表达显著(P=0.003)。
  • 流式细胞术显示PD组病变上颌骨IL-1β+中性粒细胞比例为(13.66±1.14)%,显著高于对照组(4.40±0.47)%(P<0.001)。
  • Pg体外刺激中性粒细胞后IL-1β表达显著增加(P=0.047)。
  • IL-1β+中性粒细胞与MC3T3-E1共培养后矿化结节减少、碱性磷酸酶染色变浅,TLR4和pp65蛋白表达升高,TLR4抑制剂可部分或全部逆转这些变化。

临床怎么用

  • 提示IL-1β+中性粒细胞及TLR4-NF-κB通路可能作为牙周炎骨再生的免疫治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the role and mechanism of interleukin-1β+ (IL-1β+) neutrophils in bone regulation of periodontitis in mice. Methods: The periodontitis model was established by local oral infection with Porphyromonas gingivalis (Pg). Twenty 8-week-old male C57BL/6J mice were randomly divided into 2 groups (10 mice in each group) using a random number table method: the control group [con group, 2% carboxymethylcellulose (CMC) without Pg applied topically to both buccal sides of the maxilla in mice] and the experimental group [periodontitis (PD) group, 2% CMC with Pg applied topically to both buccal sides of the maxilla in mice]. Micro-CT was used to evaluate maxillary alveolar bone. Single-cell transcriptome sequencing was employed to analyze the content of different immune cells in the diseased maxilla of mice and to screen for differentially expressed genes. HE staining and immunohistochemical staining were used to observe changes in the maxillary periodontal tissues of mice. Flow cytometry and immunofluorescence staining were applied to detect the content and expression of IL-1β+ neutrophils in the maxilla. In vitro experiments involved stimulating neutrophils with Pg to detect the expression of IL-1β, followed by sorting IL-1β+ neutrophils and constructing a co-culture model with mouse embryo osteoblast precursor cells (MC3T3-E1 cells). Alkaline phosphatase staining and alizarin red staining were used to assess the osteogenic differentiation of MC3T3-E1 cells. Western blotting was used to analyze changes in the Toll-like receptor 4-nuclear factor-κB (TLR4-NF-κB) signaling pathway. Results: The periodontitis model was successfully established in vivo. The height from the cementoenamel junction to the alveolar crest (CEJ-ABC) on the buccal side of mice in the PD group [(232.90±25.29) μm] was significantly increased compared with that in the con group [(149.50±16.69) μm, P<0.001]. The palatal CEJ-ABC [(190.70±10.67) μm] was also significantly higher than that of mice in the con group [(151.80±11.29) μm, P<0.001]. Single-cell transcriptome sequencing of mouse maxillary alveolar bone revealed that the distribution ratio of neutrophils in the PD group (0.62±0.04) was significantly higher than that in the con group (0.44±0.05, P=0.010), and the expression of IL-1β in neutrophils was significant (P=0.003). Immunohistochemical staining showed that the height of the maxillary alveolar bone in the PD group was reduced than that in the con group, as well as the bone formation ability. Flow cytometry revealed that the proportion of IL-1β+ neutrophils in the diseased maxilla of the PD group [(13.66 ± 1.14)%] was significantly higher than that in the con group [(4.40±0.47)%, P<0.001], and immunofluorescence staining also indicated an increase of IL-1β+ neutrophils in the maxillary alveolar bone of the PD group. After in vitro stimulation of neutrophils with Pg, the expression of IL-1β increased (P=0.047). After co-culturing IL-1β+ neutrophils with MC3T3-E1 cells, alizarin red staining showed a decrease in mineralized nodules, and the alkaline phosphatase staining became lighter. The protein expression levels of TLR4 and pp65 increased. All the above changes could be partially or completely reversed by TLR4 inhibitors. Conclusions: IL-1β⁺ neutrophils are significantly increased in the diseased maxillary alveolar bone of mice with periodontitis, which inhibit the osteogenic differentiation of MC3T3-E1 cells and are associated with the TLR4-NF-κB signaling pathway, providing a scientific basis for immunotherapy for bone regeneration in periodontitis. 目的: 探讨小鼠牙周炎骨调节中白细胞介素-1β阳性(IL-1β+)中性粒细胞的作用及其机制。 方法: 采用口腔局部感染牙龈卟啉单胞菌(Pg)的方式建立小鼠牙周炎模型,将20只8周龄C57BL/6J雄性小鼠通过随机数字表法随机分为2组(每组10只),对照组[使用不含Pg的2%羧甲基纤维素(CMC)局部涂抹于小鼠上颌双颊侧]和牙周炎组(PD组,使用含Pg的2%CMC局部涂抹于小鼠上颌双颊侧),显微CT评估两组小鼠上颌牙槽骨吸收情况,利用单细胞转录组学测序分析小鼠病变上颌骨中不同免疫细胞含量和筛选差异基因,使用HE染色和免疫组织化学染色等方法观察两组小鼠上颌牙周组织的变化,采用流式细胞术和免疫荧光染色等方法检测病变上颌骨内IL-1β+中性粒细胞的含量和表达。体外实验通过Pg刺激中性粒细胞后检测IL-1β的表达,进而分选IL-1β+中性粒细胞,与小鼠胚胎成骨细胞前体细胞(MC3T3-E1)构建共培养模型,茜素红染色和碱性磷酸酶染色评估MC3T3-E1的成骨分化情况;通过蛋白质印迹法分析Toll样受体4-核因子κB(TLR4-NF-κB)信号通路的变化。 结果: 体内实验成功构建小鼠牙周炎模型,PD组小鼠颊侧第二磨牙釉质牙骨质界到牙槽嵴顶的距离(CEJ-ABC)[(232.90±25.29)μm]较对照组[(149.50±16.69)μm]显著增加(P<0.001),腭侧第二磨牙CEJ-ABC[(190.70±10.67)μm]亦显著大于对照组小鼠[(151.80±11.29)μm](P<0.001);小鼠病变上颌骨的单细胞转录组学测序发现,PD组小鼠的中性粒细胞分布比例(0.62±0.04)较对照组(0.44±0.05)显著增加(P=0.010),IL-1β在中性粒细胞中表达显著(P=0.003)。HE染色和免疫组织化学染色发现,与对照组小鼠相比,PD组小鼠的上颌牙槽骨高度显著降低,骨形成能力下降。流式细胞术检测发现,PD组小鼠病变上颌骨中的IL-1β+中性粒细胞比例[(13.66±1.14)%]显著高于对照组[(4.40±0.47)%](P<0.001),免疫荧光染色也显示PD组颌骨内的IL-1β+中性粒细胞增多。Pg体外刺激中性粒细胞后,IL-1β的表达显著增加(P=0.047),将IL-1β+中性粒细胞与MC3T3-E1共培养,MC3T3-E1成骨诱导后茜素红染色显示矿化结节减少,碱性磷酸酶染色变浅,TLR4、pp65的蛋白表达水平升高,上述变化均可被TLR4抑制剂部分或全部逆转。 结论: IL-1β+中性粒细胞在牙周炎小鼠病变颌骨中显著增加,抑制MC3T3-E1细胞的成骨分化,与TLR4-NF-κB信号通路相关,为牙周炎骨再生的免疫治疗提供了依据。.

来源:Zhonghua Kou Qiang Yi Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Xu LN, Ding JC, Jiang YT, et al. [Preliminary study on the role of IL-1β+ neutrophils in bone regulation of periodontitis mice]. Zhonghua Kou Qiang Yi Xue Za Zhi. 2026. PMID: 41913611. doi:10.3760/cma.j.cn112144-20260109-00012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。